<VariationArchive RecordType="classified" VariationID="813836" VariationName="GRCh37/hg19 7p14.1(chr7:41430185-42807426)x1" VariationType="copy number loss" Accession="VCV000813836" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-03-01" MostRecentSubmission="2020-03-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="802088" VariationID="813836">
      <GeneList>
        <Gene Symbol="GLI3" FullName="GLI family zinc finger 3" GeneID="2737" HGNC_ID="HGNC:4319" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>7p14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="41960949" stop="42264268" display_start="41960949" display_stop="42264268" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="42000546" stop="42276617" display_start="42000546" display_stop="42276617" Strand="-" />
          </Location>
          <OMIM>165240</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI3">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="INHBA" FullName="inhibin subunit beta A" GeneID="3624" HGNC_ID="HGNC:6066" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>7p14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="41685114" stop="41705406" display_start="41685114" display_stop="41705406" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="41728600" stop="41742705" display_start="41728600" display_stop="41742705" Strand="-" />
          </Location>
          <OMIM>147290</OMIM>
        </Gene>
      </GeneList>
      <Name>GRCh37/hg19 7p14.1(chr7:41430185-42807426)x1</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>7p14.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" outerStart="41397582" innerStart="41430185" innerStop="42807426" outerStop="42870176" display_start="41397582" display_stop="42870176" variantLength="1472595" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(41397582_41430185)_(42807426_42870176)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(41397582_41430185)_(42807426_42870176)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh37/hg19 7p14.1(chr7:41430185-42807426)x1 AND Greig cephalopolysyndactyly syndrome" Accession="RCV001004813" Version="2">
        <ClassifiedConditionList TraitSetID="3813">
          <ClassifiedCondition DB="MedGen" ID="C0265306">Greig cephalopolysyndactyly syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-07-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-03-01" MostRecentSubmission="2020-03-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3813" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2006" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Greig cephalopolysyndactyly syndrome</ElementValue>
                <XRef ID="Greig+Cephalopolysyndactyly+Syndrome/3182" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008287" DB="MONDO" />
                <XRef ID="32985001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Greig syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polysyndactyly with peculiar skull shape</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GCPS</ElementValue>
                <XRef Type="MIM" ID="175700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Typical Greig cephalopolysyndactyly syndrome (GCPS) is characterized by macrocephaly, widely spaced eyes associated with increased interpupillary distance, preaxial polydactyly with or without postaxial polydactyly, and cutaneous syndactyly. Developmental delay, intellectual disability, or seizures appear to be uncommon manifestations (~&lt;10%) of GCPS and may be more common in individuals with large (&gt;300-kb) deletions that encompass GLI3. Approximately 20% of individuals with GCPS have hypoplasia or agenesis of the corpus callosum.</Attribute>
                <XRef ID="NBK1446" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6550" />
                <XRef ID="6550" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301619</ID>
                <ID Source="BookShelf">NBK1446</ID>
              </Citation>
              <XRef ID="380" DB="Orphanet" />
              <XRef ID="C0265306" DB="MedGen" />
              <XRef ID="MONDO:0008287" DB="MONDO" />
              <XRef Type="MIM" ID="175700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2293954" SubmissionDate="2019-07-19" DateLastUpdated="2020-03-01" DateCreated="2020-03-01">
        <ClinVarSubmissionID localKey=":Chr.7_41430185_42807426_copy number loss|Orphanet:ORPHA:380|copy:1|refcopy:2" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001164306" DateUpdated="2020-03-01" DateCreated="2020-03-01" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Goettingen" OrgID="19886" OrganizationCategory="laboratory" OrgAbbreviation="IfHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>microarray</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Oligo array</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" innerStart="41430185" innerStop="42807426" outerStart="41397582" outerStop="42870176" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">1</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="ReferenceCopyNumber">2</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <Name>
              <ElementValue Type="Preferred">Greig cephalopolysyndactyly syndrome</ElementValue>
            </Name>
            <XRef DB="Orphanet" ID="ORPHA380" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6038040</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2293954" TraitType="Finding" MappingType="Name" MappingValue="Greig cephalopolysyndactyly syndrome" MappingRef="Preferred">
        <MedGen CUI="C0265306" Name="Greig cephalopolysyndactyly syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

